| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.14 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |